Granite Point Capital Management’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
|
|||||
2022
Q3 | $3.14M | Hold |
|
|||||
2022
Q2 | $2.29M | Hold |
|
|||||
2022
Q1 | $4.41M | Buy |
|
|||||
2021
Q4 | $4.98M | Hold |
|
|||||
2021
Q3 | $4.77M | Hold |
|
|||||
2021
Q2 | $7.52M | Sell |
|
|||||
2021
Q1 | $7.26M | Sell |
|
|||||
2020
Q4 | $5.73M | Hold |
|
|||||
2020
Q3 | $6.03M | Sell |
|
|||||
2020
Q2 | $5.72M | Buy |
|
|||||
2020
Q1 | $3.83M | Sell |
|
|||||
2019
Q4 | $5.83M | Sell |
|
|||||
2019
Q3 | $5.45M | Buy |
|
|||||
2019
Q2 | $13.9M | Buy |
|
|||||
2019
Q1 | $12.7M | Buy |
|
|||||
2018
Q4 | $7.63M | Buy |
|
|||||
2018
Q3 | $10.6M | Sell |
|
|||||
2018
Q2 | $18.7M | Hold |
|
|||||
2018
Q1 | $10.1M | Buy |
|
|||||
2017
Q4 | $18.6M | Sell |
|
|||||
2017
Q3 | $15.8M | Buy |
|
|||||
2017
Q2 | $1.05M | Sell |
|
|||||
2017
Q1 | $1.37M | Buy |
|